Search

Your search keyword '"Ricupito, Alessia"' showing total 16 results
Start Over Author "Ricupito, Alessia"
16 results on '"Ricupito, Alessia"'

4. Data from Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes

Author

Calcinotto, Arianna, primary, Filipazzi, Paola, primary, Grioni, Matteo, primary, Iero, Manuela, primary, De Milito, Angelo, primary, Ricupito, Alessia, primary, Cova, Agata, primary, Canese, Rossella, primary, Jachetti, Elena, primary, Rossetti, Monica, primary, Huber, Veronica, primary, Parmiani, Giorgio, primary, Generoso, Luca, primary, Santinami, Mario, primary, Borghi, Martina, primary, Fais, Stefano, primary, Bellone, Matteo, primary, and Rivoltini, Licia, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Table 1, Figures 1-8 from Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes

Author

Calcinotto, Arianna, primary, Filipazzi, Paola, primary, Grioni, Matteo, primary, Iero, Manuela, primary, De Milito, Angelo, primary, Ricupito, Alessia, primary, Cova, Agata, primary, Canese, Rossella, primary, Jachetti, Elena, primary, Rossetti, Monica, primary, Huber, Veronica, primary, Parmiani, Giorgio, primary, Generoso, Luca, primary, Santinami, Mario, primary, Borghi, Martina, primary, Fais, Stefano, primary, Bellone, Matteo, primary, and Rivoltini, Licia, primary

Published
2023
Full Text
View/download PDF

9. Boosting anticancer vaccines

Author

Ricupito, Alessia, Grioni, Matteo, Calcinotto, Arianna, and Bellone, Matteo

Subjects
memory, adjuvant, melanoma, T cell, cancer, TRAMP, B16, vaccines, cytotoxic T lymphocytes, prostate cancer, Author's View, humanities
Abstract

Using both transplantable and oncogene-driven autochthonous tumor models challenged with dendritic cell-based vaccines, we have recently found that boosting provides a clear advantage in prophylactic settings, unless performed on an excessively tight schedule, which causes the loss of central memory T cells. In therapeutic settings, boosting turned out to be always detrimental.

Published
2013

11. Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses

Author

Jachetti, Elena, primary, Mazzoleni, Stefania, additional, Grioni, Matteo, additional, Ricupito, Alessia, additional, Brambillasca, Chiara, additional, Generoso, Luca, additional, Calcinotto, Arianna, additional, Freschi, Massimo, additional, Mondino, Anna, additional, Galli, Rossella, additional, and Bellone, Matteo, additional

Published
2013
Full Text
View/download PDF

12. Abstract 2613: Prostate cancer stem/initiating cells are targets of both innate and adaptive immunity and elicit potent immune responses against autochthonous prostate tumors.

Author

Jachetti, Elena, primary, Mazzoleni, Stefania, additional, Grioni, Matteo, additional, Ricupito, Alessia, additional, Brambillasca, Chiara, additional, Generoso, Luca, additional, Calcinotto, Arianna, additional, Freschi, Massimo, additional, Mondino, Anna, additional, Galli, Rossella, additional, and Bellone, Matteo, additional

Published
2013
Full Text
View/download PDF

13. Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes

Author

Calcinotto, Arianna, primary, Filipazzi, Paola, additional, Grioni, Matteo, additional, Iero, Manuela, additional, De Milito, Angelo, additional, Ricupito, Alessia, additional, Cova, Agata, additional, Canese, Rossella, additional, Jachetti, Elena, additional, Rossetti, Monica, additional, Huber, Veronica, additional, Parmiani, Giorgio, additional, Generoso, Luca, additional, Santinami, Mario, additional, Borghi, Martina, additional, Fais, Stefano, additional, Bellone, Matteo, additional, and Rivoltini, Licia, additional

Published
2012
Full Text
View/download PDF

16. Boosting anticancer vaccines: Too much of a good thing?

Author

Ricupito, Alessia, Grioni, Matteo, Calcinotto, Arianna, and Bellone, Matteo

Subjects
*ANTINEOPLASTIC agents, *ONCOGENES, *DENDRITIC cells, *T cells, *THERAPEUTICS
Abstract

Using both transplantable and oncogene-driven autochthonous tumor models challenged with dendritic cell-based vaccines, we have recently found that boosting provides a clear advantage in prophylactic settings, unless performed on an excessively tight schedule, which causes the loss of central memory T cells. In therapeutic settings, boosting turned out to be always detrimental. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results